One thing is likely to hurt some medtech companies more than others during the coronavirus pandemic: an elective surgical procedure slowdown. This thought had begun to emerge last week among industry watchers, but a pair of tweets over the weekend gained thousands of “likes” and retweets. The American College of Surgeons called for hospitals to […]
Baxter stock moves up on delayed Q4 results
Baxter (NYSE:BAX) shares ticked up today on fourth-quarter results that topped the consensus forecast after delayed reporting because of an internal probe. Shares of BAX were up 10.4% at $78.98 in early-afternoon trading today. The Deerfield, Ill.–based company posted losses of -$19 million, or -5¢ per share, on sales of $3.04 billion for the three months […]
Myomo drops on Q4 losses
Myomo (NYSE:MYO) shares took a hit today on fourth-quarter results that missed the consensus forecast for earnings but topped the revenue projections. The Cambridge, Mass.-based commercial-stage medical robotics company yesterday evening posted losses of $2.8 million, or -$4.81 per share, on sales of $1.5 million for the three months ended Dec. 31, 2019, for a 2.6% […]
Ocular Therapeutix dips on big losses, missed projections
Ocular Therapeutix (NSDQ:OCUL) shares were marginally down today on fourth-quarter results that came up short the consensus forecast after massive losses. The Bedford, Mass.-based ophthalmic insert maker posted losses of $26 million, or -53¢ per share, on sales of $2.3 million for the three months ended Dec. 31, 2019, for a 49.5% bottom-line slide despite nearly […]
Baxter delays 10-Q report filing again
Baxter (NYSE:BAX) today filed an SEC Form 12b-25 to confirm that it was unable to file its annual financial report on Form 10-K for the year ended Dec. 31, 2019, within the prescribed time period. The company requires additional time to complete the restatement of its previously issued financial statements, according to the Form 12b-25. The […]
TransMedics down on missed Q4 projections
TransMedics (NSDQ:TMDX) shares dipped today on fourth-quarter results that came up short of the consensus forecast. The Andover, Mass.–based company posted losses of -$9.2 million, or -43¢ per share, on sales of $6.1 million for the three months ended Dec. 31, 2019, for a 20.2% bottom-line slide on sales growth of 70.9%. Adjusted to exclude one-time […]
Conformis down on mixed Q4 results
Conformis (NSDQ:CFMS) shares took a hit today on fourth-quarter results that beat the consensus forecast on earnings but came up just shy on sales. The Billerica, Mass–based orthopedic device maker posted losses of -$5.4 million, or -8¢ per share, on sales of $19.89 million for the three months ended Dec. 31, 2019, for a more than […]
Dentsply Sirona beats Street on 4Q sales, misses on earnings
Dentsply Sirona (NSDQ:XRAY) shares took a marginal dip today on fourth-quarter results that had mixed results compared to the consensus forecast. The York, Pa.–based dental equipment maker posted profits of $102 million, or 46¢ per share, on sales of $1.1 billion for the three months ended Dec. 31, 2019, for a monstrous bottom-line gain from […]
Glaukos down despite Street-beating Q4
Glaukos (NYSE:GKOS) shares plummeted today despite fourth-quarter results that beat the consensus forecast. GKOS shares dropped down -27.4% at $44.60 per share in early-morning trading today. The San Clemente, Calif.–based ophthalmic medical technology and pharmaceutical company posted profits of $36.6 million, or 84¢ per share, on sales of $65.8 million for the three months ended Dec. […]
Inogen reports Q4 misses, reduced guidance
Inogen (NSDQ:INGN) shares skyrocketed today on fourth-quarter results that missed the consensus earnings forecast but beat The Street’s sales projections. The Goleta, Calif.-based home oxygen generator maker posted losses of -$1.4 million, or -6¢ per share, on sales of $78.9 million for the three months ended Dec. 31, 2019, sliding into losses after posting profits […]
LivaNova beats on Q4 earnings, misses on revenue
LivaNova (NSDQ:LIVN) shares took a slight dip today on fourth-quarter results that beat the consensus projections for earnings but came up short on revenue. The London-based medical device company posted losses of -$143.2 million, or -$2.96 per share, on sales of $287.6 million for the three months ended Dec. 31, 2019, for a 32% bottom-line gain […]
- 1
- 2
- 3
- …
- 231
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube